These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1890362)

  • 1. Progression of eye lesions in leprosy: ten-year follow-up study in The Netherlands.
    Hogeweg M; Faber WR
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):392-7. PubMed ID: 1890362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestation in treated multibacillary Hansen's disease.
    Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R
    Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.
    Daniel E; Koshy S; Joseph GA; Rao PS
    Indian J Ophthalmol; 2003 Jun; 51(2):155-9. PubMed ID: 12831146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular lens implantation in leprosy.
    Daniel E; Koshy S
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):9-15. PubMed ID: 12120043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of ocular complications of leprosy in institutionalized patients in NWFP Pakistan.
    Khan T; Awan AA; Kazmi HS; Shah AA; Muhammad S; Muhammad S
    J Ayub Med Coll Abbottabad; 2002; 14(4):29-33. PubMed ID: 12688099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term follow up of patients with multibacillary leprosy and HIV infection.
    Jacob M; George S; Pulimood S; Nathan N
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):392-5. PubMed ID: 9030104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of disabling ocular complications of leprosy: a global study.
    Ffytche TJ
    Indian J Lepr; 1998; 70(1):49-59. PubMed ID: 9598405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I; Dogra S; Kumar B; Radotra BD
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cataract surgery in a leprosy population in Liberia.
    Frucht-Pery J; Feldman ST
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):20-4. PubMed ID: 8326176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical ocular study in leprosy patients at a sanitary dermatological hospital in Brazil.
    Oréfice F; Boratto LM
    Indian J Lepr; 1998; 70(2):189-95. PubMed ID: 9724854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia.
    Courtright P; Daniel E; Sundarrao ; Ravanes J; Mengistu F; Belachew M; Celloria RV; Ffytche T
    Lepr Rev; 2002 Sep; 73(3):225-38. PubMed ID: 12449887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of blindness in leprosy and the role of the Vision 2020 Programme.
    Hogeweg M; Keunen JE
    Eye (Lond); 2005 Oct; 19(10):1099-105. PubMed ID: 16304590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of eye complications in leprosy in Prakasam District (Andhra Pradesh).
    Reddy SC; Raju BD; Achary NR
    Lepr India; 1981 Apr; 53(2):231-7. PubMed ID: 7253576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study of eye complications in leprosy.
    Rawal RC; Kar PK; Desai RN; Shah BH
    Indian J Lepr; 1984; 56(2):232-40. PubMed ID: 6548492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
    van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
    Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy.
    Daniel E; Ffytche TJ; Kempen JH; Rao PS; Diener-West M; Courtright P
    Br J Ophthalmol; 2006 Aug; 90(8):949-54. PubMed ID: 16707521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.